528 related articles for article (PubMed ID: 10931041)
21. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
22. E-Cadherin, beta -Catenin and cadmium carcinogenesis.
Pearson CA; Prozialeck WC
Med Hypotheses; 2001 May; 56(5):573-81. PubMed ID: 11388771
[TBL] [Abstract][Full Text] [Related]
23. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion.
Suriano G; Mulholland D; de Wever O; Ferreira P; Mateus AR; Bruyneel E; Nelson CC; Mareel MM; Yokota J; Huntsman D; Seruca R
Oncogene; 2003 Aug; 22(36):5716-9. PubMed ID: 12944922
[TBL] [Abstract][Full Text] [Related]
24. Exchange of catenins in cadherin-catenin complex.
Klingelhöfer J; Troyanovsky RB; Laur OY; Troyanovsky S
Oncogene; 2003 Feb; 22(8):1181-8. PubMed ID: 12606944
[TBL] [Abstract][Full Text] [Related]
25. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH
J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486
[TBL] [Abstract][Full Text] [Related]
26. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
27. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
29. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
30. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
[TBL] [Abstract][Full Text] [Related]
31. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
32. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
33. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
34. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells.
Hiscox S; Jiang WG
Biochem Biophys Res Commun; 1999 Aug; 261(2):406-11. PubMed ID: 10425198
[TBL] [Abstract][Full Text] [Related]
35. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
[TBL] [Abstract][Full Text] [Related]
36. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
38. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH
Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560
[TBL] [Abstract][Full Text] [Related]
39. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
40. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
